
Genomics Market by Product & Service (Consumables, Services, Systems & Software), Technology (Microarray, Nucleic Acid Extraction & Purification, PCR), End-User, Application - Global Forecast 2024-2030
Description
Genomics Market by Product & Service (Consumables, Services, Systems & Software), Technology (Microarray, Nucleic Acid Extraction & Purification, PCR), End-User, Application - Global Forecast 2024-2030
The Genomics Market size was estimated at USD 27.36 billion in 2023 and expected to reach USD 31.51 billion in 2024, at a CAGR 15.63% to reach USD 75.63 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Genomics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Genomics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biomatters Limited, Bionano Genomics, Inc., C2i Genomics, Congenica Ltd., Danaher Corporation, Dante Labs Inc., Eagle Genomics, Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fabric Genomics, Inc., Helix OpCo, LLC, Merck & Co., Inc., Myriad Genetics, Inc., Nest Health Tech Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., QIAGEN GmbH, Quest Diagnostics Incorporated, Rapid Genomics by LGC Biosearch Technologies, Thermo Fisher Scientific Inc., and Vizgen, Inc..
Market Segmentation & Coverage
This research report categorizes the Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product & Service
Consumables
Services
Systems & Software
Technology
Microarray
Nucleic Acid Extraction & Purification
PCR
Sequencing
End-User
Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Research Centers & Academic
Application
Agriculture & Animal Research
Diagnostics
Drug Discovery & Development
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Genomics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Genomics Market?
3. What are the technology trends and regulatory frameworks in the Genomics Market?
4. What is the market share of the leading vendors in the Genomics Market?
5. Which modes and strategic moves are suitable for entering the Genomics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
180 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Genomics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising number of government funding for the R&D in genome projects
- 5.1.1.2. Growing adoption of genomic medicine and precision public health
- 5.1.1.3. Development of genetic tools in agrigenomics
- 5.1.2. Restraints
- 5.1.2.1. High cost of equipment and consumables
- 5.1.3. Opportunities
- 5.1.3.1. Growth of newborn genetic screening programs and sequencing technologies
- 5.1.3.2. Adoption of advanced computational technologies to launch innovative products and services
- 5.1.4. Challenges
- 5.1.4.1. Limited skilled and trained personnel
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Genomics Market, by Product & Service
- 6.1. Introduction
- 6.2. Consumables
- 6.3. Services
- 6.4. Systems & Software
- 7. Genomics Market, by Technology
- 7.1. Introduction
- 7.2. Microarray
- 7.3. Nucleic Acid Extraction & Purification
- 7.4. PCR
- 7.5. Sequencing
- 8. Genomics Market, by End-User
- 8.1. Introduction
- 8.2. Government Institutes
- 8.3. Hospitals & Clinics
- 8.4. Pharmaceutical & Biotechnology Companies
- 8.5. Research Centers & Academic
- 9. Genomics Market, by Application
- 9.1. Introduction
- 9.2. Agriculture & Animal Research
- 9.3. Diagnostics
- 9.4. Drug Discovery & Development
- 10. Americas Genomics Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Genomics Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Genomics Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. 10x Genomics, Inc.
- 14.1.2. Agilent Technologies, Inc.
- 14.1.3. Bio-Rad Laboratories, Inc.
- 14.1.4. Biomatters Limited
- 14.1.5. Bionano Genomics, Inc.
- 14.1.6. C2i Genomics
- 14.1.7. Congenica Ltd.
- 14.1.8. Danaher Corporation
- 14.1.9. Dante Labs Inc.
- 14.1.10. Eagle Genomics
- 14.1.11. Eppendorf SE
- 14.1.12. Eurofins Scientific SE
- 14.1.13. F. Hoffmann-La Roche AG
- 14.1.14. Fabric Genomics, Inc.
- 14.1.15. Helix OpCo, LLC
- 14.1.16. Merck & Co., Inc.
- 14.1.17. Myriad Genetics, Inc.
- 14.1.18. Nest Health Tech Inc.
- 14.1.19. Novogene Co., Ltd.
- 14.1.20. Oxford Nanopore Technologies PLC
- 14.1.21. Pacific Biosciences of California, Inc.
- 14.1.22. Personalis, Inc.
- 14.1.23. QIAGEN GmbH
- 14.1.24. Quest Diagnostics Incorporated
- 14.1.25. Rapid Genomics by LGC Biosearch Technologies
- 14.1.26. Thermo Fisher Scientific Inc.
- 14.1.27. Vizgen, Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. GENOMICS MARKET RESEARCH PROCESS
- FIGURE 2. GENOMICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GENOMICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. GENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GENOMICS MARKET DYNAMICS
- FIGURE 7. GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
- FIGURE 8. GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 10. GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.